Table 1.
Demographic Characteristics of Study Participantsa
| Variable | Men (n = 197) | Women (n = 253) | All (n = 450) | P Value |
|---|---|---|---|---|
| Age, y | 55.8 ± 9.9 (55.0) | 55.1 ± 9.1 (54.0) | 55.4 ± 9.5 (55.0) | .45 |
| Age at diabetes onset, y | 45.9 ± 10.1 (46.0) | 45.0 ± 9.6 (45.0) | 45.4 ± 9.8 (46.0) | .31 |
| Diabetes duration, y | 10.5 ± 9.0 (8.0) | 10.1 ± 7.5 (8.0) | 10.3 ± 8.2 (8.0) | .71 |
| BMI, kg/m2 | 33.0 ± 7.6 (31.5) | 37.7 ± 8.9 (36.3) | 35.6 ± 8.7 (34.0) | <.0001 |
| Systolic BP, mm Hg | 132.4 ± 18.2 (131.0) | 133.4 ± 19.6 (131.0) | 133.0 ± 19.0 (131.0) | .69 |
| Diastolic BP, mm Hg | 78.8 ± 11.0 (79.0) | 76.5 ± 11.3 (77.0) | 77.5 ± 11.2 (77.0) | .03 |
| Hypertension, % | 49.7 | 50.6 | 50.2 | .86 |
| Lipid meds, % | 51.3 | 53.2 | 52.4 | .69 |
| History of cardiovascular disease, % | 28.4 | 26.2 | 27.2 | .60 |
| Smokers, % | .002 | |||
| Current | 41.1 | 30.4 | 35.1 | |
| Past | 25.9 | 19.8 | 22.4 | |
| Insulin use, % | 43.1 | 39.5 | 43.1 | .44 |
| Hormone replacement therapy, % | 28.3 | 28.3 |
a
Unless indicated otherwise, results are shown as mean ± SD (median). P values are derived from a test comparing the distributions between men and women.